JOVY SKARSTEIN

download JOVY SKARSTEIN

of 7

Transcript of JOVY SKARSTEIN

  • 8/13/2019 JOVY SKARSTEIN

    1/7

    JOVY SKARSTEIN

    GENERIC NAME MECHANISM OFACTION

    INDICATIONS CONTRAINDICATION SIDE EFFECT HEALTHTEACHING

    SIMVASTATIN

    BRAND NAME:

    ZOCOR

    DOSAGE:

    For Heterozygousfamilialhypercholesterolemia:

    Children less than10 years:

    5 mg once daily inthe eveningincreasing to 10 mgonce daily after 4weeks and to 20 mgonce daily after 8

    weeks as tolerated.Children greater thanor equal to 10 years:10 mg once daily inthe eveningincreasing to 20 mg

    -Simvastatins act

    bycompetitivelyinhibitingHMG-CoA reductase,thefirst committedenzyme of theHMG-CoAreductase pathway.Because statinsare similar to HMG-CoA on amolecular level,

    they take the placeof HMG-CoA in theenzyme andreduce the rate bywhich it is able toproducemevalonate,thenext molecule inthecascade thateventually

    producescholesterol,as wellas a number ofother compounds.This ultimatelyreduces cholesterol

    -Simvastatin is

    indicated for thetreatment ofhypercholesterolemia.Simvastatin isindicated togetherwith lifestyle changes(diet, weight-loss,exercise) to reducethe amount ofcholesterol (a fat-likesubstance) and

    certain other fattysubstances in yourblood. Simvastatin isin a class ofprescriptions calledHMG-CoA reductaseinhibitors (statins). Itworks by slowing theproduction ofcholesterol in the

    body.

    Buildup of cholesteroland fats along thewalls of your arteries(a process known as

    -Hypersensitivity to

    any component ofSimvastatin.-Active liver disease orunexplained persistentelevations of serumtransaminases

    -Simvastatin

    side effects thatyou shouldreport to yourhealth careprofessional ordoctor as soonas possible:- constipation;- difficultybreathing orswallowing;

    - extremetiredness;- fever;- flu-likesymptoms;- hives;- hoarseness;- itching;- lack of energy;- loss of

    appetite;- muscle pain,tenderness, orweakness;- nausea;- pain in the

    -Instruct patient

    to takemedication asdirected, not toskip doses ordouble up onmissed doses.

    Advise patient toavoid drinkingmore than 1 qt ofgrapefruit

    juice/day during

    therapy.Medication helpscontrol but doesnot cure elevatedserumcholesterollevels.

    -Advise patientthat this

    medicationshould be usedin conjunctionwith dietrestrictions (fat,cholesterol,

    http://en.wikipedia.org/wiki/Competitive_inhibitorhttp://en.wikipedia.org/wiki/Competitive_inhibitorhttp://en.wikipedia.org/wiki/HMG-CoA_reductasehttp://en.wikipedia.org/wiki/HMG-CoA_reductasehttp://en.wikipedia.org/wiki/Enzymehttp://en.wikipedia.org/wiki/HMG-CoA_reductase_pathwayhttp://en.wikipedia.org/wiki/HMG-CoA_reductase_pathwayhttp://en.wikipedia.org/wiki/Mevalonatehttp://en.wikipedia.org/wiki/Mevalonate_pathwayhttp://en.wikipedia.org/wiki/Mevalonate_pathwayhttp://en.wikipedia.org/wiki/Mevalonate_pathwayhttp://en.wikipedia.org/wiki/Mevalonate_pathwayhttp://en.wikipedia.org/wiki/Mevalonate_pathwayhttp://en.wikipedia.org/wiki/Mevalonate_pathwayhttp://en.wikipedia.org/wiki/Mevalonate_pathwayhttp://en.wikipedia.org/wiki/Mevalonate_pathwayhttp://en.wikipedia.org/wiki/Mevalonatehttp://en.wikipedia.org/wiki/HMG-CoA_reductase_pathwayhttp://en.wikipedia.org/wiki/HMG-CoA_reductase_pathwayhttp://en.wikipedia.org/wiki/Enzymehttp://en.wikipedia.org/wiki/HMG-CoA_reductasehttp://en.wikipedia.org/wiki/HMG-CoA_reductasehttp://en.wikipedia.org/wiki/Competitive_inhibitorhttp://en.wikipedia.org/wiki/Competitive_inhibitor
  • 8/13/2019 JOVY SKARSTEIN

    2/7

    once daily after 6weeks and to 40 mgonce daily after 12weeks as tolerated.

    10 to 17 years:

    Initial dose: 10 mgorally once a day inthe evening.Maintenance dose: 10to 40 mg/day (themaximumrecommended dose is40 mg/day). Dosageincreases should bedone at intervals of 4weeks or more. UsualAdult Dose ofSimvastatin forHyperlipidemia:

    Initial dose: 10 to 20mg orally once a dayin the evening.

    Maintenance dose: 5to 40 mg orally once aday in the evening.

    For patients at highrisk for a CHD event

    via severalmechanisms.

    Inhibitingcholesterol

    synthesis

    By inhibiting HMG-CoA reductase,statins block thepathway forsynthesizingcholesterol in theliver. This issignificant becausemost circulatingcholesterol comesfrom internalmanufacture ratherthan the diet. Whenthe liver can nolonger producecholesterol, levelsof cholesterol in theblood will fall.Cholesterol

    synthesis appearsto occur mostly atnight,[47]so statinswith shorthalf-livesare usually taken atnight to maximize

    atherosclerosis)decreases blood flowand, therefore, theoxygen supply to yourheart, brain, and other

    parts of your body.Lowering your bloodlevel of cholesteroland fats may help todecrease yourchances of gettingheart disease, angina(chest pain), strokes,and heart attacks. Inaddition to taking acholesterol-loweringprescription, makingcertain changes inyour daily habits canalso lower yourcholesterol bloodlevels. You should eata diet that is low insaturated fat andcholesterol (seeSPECIAL DIETARY),

    exercise 30 minuteson most, if not alldays, and lose weightif you are overweight.

    A derivative of

    upper right partof the stomach;- rash;- swelling of theface, throat,

    tongue, lips,eyes, hands,feet, ankles, orlower legs;- unusualbleeding orbruising;- yellowing ofthe skin oreyes;

    carbohydrates,alcohol),exercise, andcessation ofsmoking.

    -Instruct patientto notify healthcare professionalif unexplainedmuscle pain,tenderness, orweaknessoccurs,especially ifaccompanied byfever or malaise.

    -Advise patient towear sunscreenand protectiveclothing topreventphotosensitivityreactions (rare).

    -Instruct patientto notify healthcare professionalof all Rx or OTCmedications,vitamins, or

    http://en.wikipedia.org/wiki/Statin#cite_note-47http://en.wikipedia.org/wiki/Statin#cite_note-47http://en.wikipedia.org/wiki/Statin#cite_note-47http://en.wikipedia.org/wiki/Half-lifehttp://en.wikipedia.org/wiki/Half-lifehttp://en.wikipedia.org/wiki/Statin#cite_note-47
  • 8/13/2019 JOVY SKARSTEIN

    3/7

    due to existing CHD,diabetes, peripheralvessel disease,history of stroke orother cerebrovascular

    disease, therecommendedstarting dose is 40 mgorally once a day.

    Usual Adult Dosefor CardiovascularRisk Reduction:

    Initial dose: 10 to 20mg orally once a dayin the evening.Maintenance dose: 5to 40 mg orally once aday in the evening.

    For patients at highrisk for a CHD eventdue to existing CHD,diabetes, peripheralvessel disease,

    history of stroke orother cerebrovasculardisease, therecommendedstarting dose is 40 mgorally once a day.

    their effect. Studieshave showngreater LDL andtotal cholesterolreductions in the

    short-actingsimvastatin takenat night rather thanthe morning,[48][49]but have shown nodifference in thelong-actingatorvastatin.[50]

    Increasing LDLuptakeIn rabbits,hepatocytes (livercells) sense thereduced levels ofliver cholesteroland seek tocompensate bysynthesizingLDLreceptors to drawcholesterol out of

    the circulation.

    [51]

    This isaccomplished viaprotease enzymesthat cleave aprotein called

    lovastatin and potentcompetitive inhibitor of3-hydroxy-3-methylglutarylcoenzyme A

    reductase(hydroxymethylglutarylCOA reductases),which is the rate-limiting enzyme incholesterolbiosynthesis. It mayalso interfere withsteroid hormoneproduction. Due to theinduction of hepaticLDL receptors, itincreases breakdownof LDL cholesterol.

    herbal productsbeing taken andconsult healthcare professionalbefore taking any

    new medications.

    -Advise patient tonotify health careprofessional ofmedicationregimen beforetreatment orsurgery.

    -Instruct femalepatients to notifyhealth careprofessionalpromptly ifpregnancy isplanned orsuspected.

    Emphasize theimportance of

    follow-up examsto determineeffectiveness andto monitor forside effects.

    http://en.wikipedia.org/wiki/Statin#cite_note-48http://en.wikipedia.org/wiki/Statin#cite_note-48http://en.wikipedia.org/wiki/Statin#cite_note-48http://en.wikipedia.org/wiki/Statin#cite_note-50http://en.wikipedia.org/wiki/Statin#cite_note-50http://en.wikipedia.org/wiki/Statin#cite_note-50http://en.wikipedia.org/wiki/Hepatocytehttp://en.wikipedia.org/wiki/LDL_receptorhttp://en.wikipedia.org/wiki/LDL_receptorhttp://en.wikipedia.org/wiki/Statin#cite_note-Ma1986-51http://en.wikipedia.org/wiki/Statin#cite_note-Ma1986-51http://en.wikipedia.org/wiki/Statin#cite_note-Ma1986-51http://en.wikipedia.org/wiki/Proteasehttp://en.wikipedia.org/wiki/Proteasehttp://en.wikipedia.org/wiki/Statin#cite_note-Ma1986-51http://en.wikipedia.org/wiki/LDL_receptorhttp://en.wikipedia.org/wiki/LDL_receptorhttp://en.wikipedia.org/wiki/Hepatocytehttp://en.wikipedia.org/wiki/Statin#cite_note-50http://en.wikipedia.org/wiki/Statin#cite_note-48http://en.wikipedia.org/wiki/Statin#cite_note-48
  • 8/13/2019 JOVY SKARSTEIN

    4/7

    "membrane-boundsterol regulatoryelement bindingprotein", whichmigrates to the

    nucleus andcauses increasedproduction ofvarious otherproteins andenzymes, includingtheLDL receptor.The LDL receptorthen relocates tothe livercellmembrane andbinds to passingLDL andVLDLparticles (the "badcholesterol" linkedto disease). LDLand VLDL aredrawn out ofcirculation into theliver, where thecholesterol is

    reprocessed intobile salts. Theseare excreted, andsubsequentlyrecycled mostly byan internal bile salt

    http://en.wikipedia.org/wiki/Sterol_regulatory_element_binding_proteinhttp://en.wikipedia.org/wiki/Sterol_regulatory_element_binding_proteinhttp://en.wikipedia.org/wiki/Sterol_regulatory_element_binding_proteinhttp://en.wikipedia.org/wiki/Cell_nucleushttp://en.wikipedia.org/wiki/LDL_receptorhttp://en.wikipedia.org/wiki/Cell_membranehttp://en.wikipedia.org/wiki/Cell_membranehttp://en.wikipedia.org/wiki/Low_density_lipoproteinhttp://en.wikipedia.org/wiki/Very_low_density_lipoproteinhttp://en.wikipedia.org/wiki/Very_low_density_lipoproteinhttp://en.wikipedia.org/wiki/Low_density_lipoproteinhttp://en.wikipedia.org/wiki/Cell_membranehttp://en.wikipedia.org/wiki/Cell_membranehttp://en.wikipedia.org/wiki/LDL_receptorhttp://en.wikipedia.org/wiki/Cell_nucleushttp://en.wikipedia.org/wiki/Sterol_regulatory_element_binding_proteinhttp://en.wikipedia.org/wiki/Sterol_regulatory_element_binding_proteinhttp://en.wikipedia.org/wiki/Sterol_regulatory_element_binding_protein
  • 8/13/2019 JOVY SKARSTEIN

    5/7

    circulation.

    Other effectsSimvastatin exhibitaction beyond lipid-

    lowering activity inthe prevention ofatherosclerosis.TheASTEROIDtrial showed directultrasoundevidence ofatheromaregression duringstatin therapy.[52]Researchershypothesize thatstatins preventcardiovasculardisease via fourproposedmechanisms (allsubjects of a largebody of biomedicalresearch):[53]

    1. Improveendothelialfunction

    2. Modulateinflammatoryresponses

    http://en.wikipedia.org/wiki/Atherosclerosishttp://en.wikipedia.org/wiki/ASTEROID_trialhttp://en.wikipedia.org/wiki/ASTEROID_trialhttp://en.wikipedia.org/wiki/Intravascular_ultrasoundhttp://en.wikipedia.org/wiki/Atheromahttp://en.wikipedia.org/wiki/Statin#cite_note-Nissen2006-52http://en.wikipedia.org/wiki/Statin#cite_note-Nissen2006-52http://en.wikipedia.org/wiki/Statin#cite_note-Nissen2006-52http://en.wikipedia.org/wiki/Cardiovascular_diseasehttp://en.wikipedia.org/wiki/Cardiovascular_diseasehttp://en.wikipedia.org/wiki/Statin#cite_note-Furberg-53http://en.wikipedia.org/wiki/Statin#cite_note-Furberg-53http://en.wikipedia.org/wiki/Statin#cite_note-Furberg-53http://en.wikipedia.org/wiki/Endotheliumhttp://en.wikipedia.org/wiki/Inflammationhttp://en.wikipedia.org/wiki/Inflammationhttp://en.wikipedia.org/wiki/Endotheliumhttp://en.wikipedia.org/wiki/Statin#cite_note-Furberg-53http://en.wikipedia.org/wiki/Cardiovascular_diseasehttp://en.wikipedia.org/wiki/Cardiovascular_diseasehttp://en.wikipedia.org/wiki/Statin#cite_note-Nissen2006-52http://en.wikipedia.org/wiki/Atheromahttp://en.wikipedia.org/wiki/Intravascular_ultrasoundhttp://en.wikipedia.org/wiki/ASTEROID_trialhttp://en.wikipedia.org/wiki/ASTEROID_trialhttp://en.wikipedia.org/wiki/Atherosclerosis
  • 8/13/2019 JOVY SKARSTEIN

    6/7

    3. Maintainplaquestability

    4. Preventthrombus

    formation

    Statins may evenbenefit thosewithout highcholesterol. In2008, the JUPITERstudy showedfewer strokes,heart attacks, andsurgeries even for

    patients who hadno history ofhighcholesterol or heartdisease, but onlyelevatedC-reactiveprotein levels.There were also20% fewer deaths(mainly fromreduction in cancer

    deaths) thoughdeaths fromcardiovascularcauses were notreduced.

    http://en.wikipedia.org/wiki/Atherosclerosishttp://en.wikipedia.org/wiki/Thrombosishttp://en.wikipedia.org/wiki/Hyperlipidemiahttp://en.wikipedia.org/wiki/Hyperlipidemiahttp://en.wikipedia.org/wiki/C-reactive_proteinhttp://en.wikipedia.org/wiki/C-reactive_proteinhttp://en.wikipedia.org/wiki/C-reactive_proteinhttp://en.wikipedia.org/wiki/C-reactive_proteinhttp://en.wikipedia.org/wiki/Hyperlipidemiahttp://en.wikipedia.org/wiki/Hyperlipidemiahttp://en.wikipedia.org/wiki/Thrombosishttp://en.wikipedia.org/wiki/Atherosclerosis
  • 8/13/2019 JOVY SKARSTEIN

    7/7